Clinical outcomes of Covid-19 in patients with sickle cell disease in French Guiana

Abstract

Objectives

French Guiana also suffered concrete epidemiological consequences of the SARS-CoV2 epidemic. These regions are home to a large number of sickle cell patients who are at risk of developing severe forms of COVID-19. This study aimed to describe the characteristics and prognosis of patients with sickle disease infected with SARS-CoV2 during the first and second epidemic waves of 2020 in French Guiana.

Design

We conducted a multicenter, retrospective cohort study that included sickle cell patients followed up in French Guiana.

Results

Among the 79 patients infected with SARS-CoV2, there were 26 children <18 years.

Forty-two patients were hospitalized and 37 were outpatients. Respiratory illness (38%), vasoocclusive crises (18%), and acute chest syndrome (8%) were the main causes of hospitalization. There were two cases of pulmonary embolism and one case of deep limb thrombosis. Seven patients were transferred to the ICU. Of these, three received mechanical ventilation, and two died. The deceased patients had the SS phenotype (a 16-year-old boy and a 32-year-old man), both of whom exhibited severe pneumonitis complicated by COVID-19.

Conclusion

Despite the two deaths, the overall outcome was favorable.